Tobias M Hohl1. 1. Infectious Disease Service, Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Abstract
PURPOSE OF REVIEW: Invasive aspergillosis is a worldwide disease that primarily affects immune-compromised patients, agricultural workers with corneal abrasions, individuals with structural lung disease, and patients with primary immune deficiency. The critical function of the immune system is to prevent the germination of airborne conidia into tissue-invasive hyphae. This review covers recent advances that shape our understanding of anti-Aspergillus immunity at the molecular and cellular level. RECENT FINDINGS: Host defense against conidia and hyphae occurs via distinct molecular mechanisms that involve intracellular and extracellular killing pathways, as well as cooperation between different myeloid cell subsets. The strength and efficacy of the host response is shaped by the tissue microenvironment. In preclinical models of disease, host immune augmentation strategies have yielded benefits, yet translating these insights into therapeutic strategies in humans remains challenging. SUMMARY: Although advances in early diagnostic strategies and in antifungal drugs have ameliorated clinical outcomes of invasive aspergillosis, further improvements depend on gaining deeper insight into and translating advances in anti-Aspergillus immunity.
PURPOSE OF REVIEW: Invasive aspergillosis is a worldwide disease that primarily affects immune-compromised patients, agricultural workers with corneal abrasions, individuals with structural lung disease, and patients with primary immune deficiency. The critical function of the immune system is to prevent the germination of airborne conidia into tissue-invasive hyphae. This review covers recent advances that shape our understanding of anti-Aspergillus immunity at the molecular and cellular level. RECENT FINDINGS: Host defense against conidia and hyphae occurs via distinct molecular mechanisms that involve intracellular and extracellular killing pathways, as well as cooperation between different myeloid cell subsets. The strength and efficacy of the host response is shaped by the tissue microenvironment. In preclinical models of disease, host immune augmentation strategies have yielded benefits, yet translating these insights into therapeutic strategies in humans remains challenging. SUMMARY: Although advances in early diagnostic strategies and in antifungal drugs have ameliorated clinical outcomes of invasive aspergillosis, further improvements depend on gaining deeper insight into and translating advances in anti-Aspergillus immunity.
Authors: Nadia R Cohen; Raju V V Tatituri; Amariliz Rivera; Gerald F M Watts; Edy Y Kim; Asako Chiba; Beth B Fuchs; Eleftherios Mylonakis; Gurdyal S Besra; Stuart M Levitz; Manfred Brigl; Michael B Brenner Journal: Cell Host Microbe Date: 2011-11-17 Impact factor: 21.023
Authors: Jessica L Werner; Melissa A Gessner; Lauren M Lilly; Michael P Nelson; Allison E Metz; Dawn Horn; Chad W Dunaway; Jessy Deshane; David D Chaplin; Casey T Weaver; Gordon D Brown; Chad Steele Journal: Infect Immun Date: 2011-08-01 Impact factor: 3.441
Authors: William J Steinbach; Kieren A Marr; Elias J Anaissie; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; Senu Apewokin; David L Horn Journal: J Infect Date: 2012-08-13 Impact factor: 6.072
Authors: Noushine Mossadegh-Keller; Sandrine Sarrazin; Prashanth K Kandalla; Leon Espinosa; E Richard Stanley; Stephen L Nutt; Jordan Moore; Michael H Sieweke Journal: Nature Date: 2013-04-10 Impact factor: 49.962
Authors: R Robert Vethanayagam; Nikolaos G Almyroudis; Melissa J Grimm; David C Lewandowski; Christine T N Pham; Timothy S Blackwell; Ruta Petraitiene; Vidmantas Petraitis; Thomas J Walsh; Constantin F Urban; Brahm H Segal Journal: PLoS One Date: 2011-12-07 Impact factor: 3.240
Authors: Sixto M Leal; Sanhita Roy; Chairut Vareechon; Steven deJesus Carrion; Heather Clark; Manuel S Lopez-Berges; Antonio Di Pietro; Antonio diPietro; Marcus Schrettl; Nicola Beckmann; Bernhard Redl; Hubertus Haas; Eric Pearlman Journal: PLoS Pathog Date: 2013-07-11 Impact factor: 6.823
Authors: Evelyn Santos Guerra; Chrono K Lee; Charles A Specht; Bhawna Yadav; Haibin Huang; Ali Akalin; Jun R Huh; Christian Mueller; Stuart M Levitz Journal: PLoS Pathog Date: 2017-01-17 Impact factor: 6.823
Authors: Rahul S Vedula; Matthew P Cheng; Christine E Ronayne; Dimitrios Farmakiotis; Vincent T Ho; Sophia Koo; Francisco M Marty; R Coleman Lindsley; Tyler D Bold Journal: Blood Adv Date: 2021-01-12
Authors: Samuel M Gonçalves; Katrien Lagrou; Cláudia S Rodrigues; Cláudia F Campos; Leticia Bernal-Martínez; Fernando Rodrigues; Ricardo Silvestre; Laura Alcazar-Fuoli; Johan A Maertens; Cristina Cunha; Agostinho Carvalho Journal: Front Microbiol Date: 2017-11-29 Impact factor: 5.640